drugset / Trial / NCT05901714

A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam

NCT05901714

Phase 1 Completed 65 enrolled Bristol-Myers Squibb
Non-randomizedSequentialOpen-labelTreatment

Summary

This study will consist of 2 parts. The study will evaluate whether administration of phenytoin impacts the single-dose drug levels of afimetoran and BMT-271199 (Part 1) and will evaluate whether multiple administrations of afimetoran impact the drug levels of midazolam and 1-hydroxymidazolam (Part 2).

Timeline

Start
2023-06-14
Primary completion
2024-04-11
Completion
2024-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Afimetoran Small molecule
Subject Midazolam Small molecule
Subject Phenytoin Unknown

Indications

No indication recorded.